Avanos Medical Inc.
11/04/2024 | Press release | Distributed by Public on 11/04/2024 15:12
Material Event Form 8 K
Item 8.01 Other Events
On November 1, 2024, the Board of Directors of the Company approved a new one-year program under which the Company may repurchase up to $25.0 million of the Company's common stock.
Repurchases under the Company's new program will be made from time to time at management's discretion on the open market or through privately negotiated transactions in compliance with Rules 10b5-1 and 10b-18 under the Securities Exchange Act, as amended, subject to market conditions, applicable legal requirements and other relevant factors; provided, however, that the share repurchase program will not commence until at least one full trading day following the public release of any material non-public information regarding the Company.
The share repurchase program does not obligate the Company to purchase any particular amount of common stock and may be suspended, modified or discontinued by the Company without prior notice.